Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

Lundbeck

Status and phase: Completed; Phase 3

Conditions: Primary Insomnia

Treatments: Drug: Comparator: placebo (unspecified); Drug: gaboxadol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00094627

MK0928-004

2004_087

0928-004

Details and patient eligibility

About

The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.

Enrollment: 465 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients with a diagnosis of primary insomnia and in good physical and mental health

Exclusion criteria

• Adult patients with other medical , neurological and sleep disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind